Skip to main content
Log in

When falsified medicines enter the supply chain: Description of an incident in Kenya and lessons learned for rapid response

  • Original Article
  • Published:
Journal of Public Health Policy Aims and scope Submit manuscript

Abstract

Falsified and substandard medicines present serious concerns for public health. We describe an event that occurred in late 2011 involving falsified antiretroviral medicines found in the supplies of Médecins Sans Frontières (MSF) projects in Kenya. We discuss factors contributing to these falsified medicines entering the supply chain as well as the response by MSF and others. We make recommendations to help defend against future episodes of entry of falsified medicines into the supply chain as well as comments on appropriate responses in cases of falsified medicines.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1

Similar content being viewed by others

References

Download references

Author information

Authors and Affiliations

Authors

Additional information

The authors describe and analyze how and with what consequences falsified medicines entered the supply chain in Kenya. How did Médecins Sans Frontiéres and the government respond?

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cohn, J., von Schoen-Angerer, T., Jambert, E. et al. When falsified medicines enter the supply chain: Description of an incident in Kenya and lessons learned for rapid response. J Public Health Pol 34, 22–30 (2013). https://doi.org/10.1057/jphp.2012.53

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1057/jphp.2012.53

Keywords

Navigation